These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20949455)

  • 21. [Comparison of paired box genes 8 and 2 expression in epithelium tissues and the related tumors].
    Song Y; Huang X; Shen GH; Liu XY; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):424-428. PubMed ID: 28635231
    [No Abstract]   [Full Text] [Related]  

  • 22. Gynecologic Serous Carcinoma: An Immunohistochemical Analysis of Malignant Body Fluid Specimens.
    Ren S; Klump W
    Arch Pathol Lab Med; 2019 Jun; 143(6):677-682. PubMed ID: 29688031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia.
    Shukla A; Thomas D; Roh MH
    Int J Gynecol Pathol; 2013 Jan; 32(1):116-21. PubMed ID: 23202787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study.
    Tacha D; Zhou D; Cheng L
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):293-9. PubMed ID: 21285870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
    Ordóñez NG
    Mod Pathol; 2013 Aug; 26(8):1132-43. PubMed ID: 23503645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases.
    Fujiwara M; Taube J; Sharma M; McCalmont TH; Kim J
    J Cutan Pathol; 2010 Sep; 37(9):938-43. PubMed ID: 20492080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity For PAX2, PAX8, and GATA-3.
    Roma AA
    Int J Gynecol Pathol; 2014 Nov; 33(6):624-9. PubMed ID: 25272303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility.
    Schmitt AC; Cohen C; Siddiqui MT
    Cancer Cytopathol; 2010 Aug; 118(4):196-202. PubMed ID: 20731005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.
    Kuroda N; Agatsuma Y; Tamura M; Martinek P; Hes O; Michal M
    Int J Clin Exp Pathol; 2015; 8(2):2131-8. PubMed ID: 25973115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy.
    Wang Y; Wang Y; Li J; Yuan Z; Yuan B; Zhang T; Cragun JM; Kong B; Zheng W
    J Hematol Oncol; 2013 Aug; 6():60. PubMed ID: 23958394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas.
    Ordóñez NG
    Mod Pathol; 2013 Apr; 26(4):553-62. PubMed ID: 23196794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
    Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
    Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic utility of PAX8 in differentiation of mullerian from non-mullerian tumors.
    Heidarpour M; Tavanafar Z
    Adv Biomed Res; 2014; 3():96. PubMed ID: 24800185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
    Laury AR; Hornick JL; Perets R; Krane JF; Corson J; Drapkin R; Hirsch MS
    Am J Surg Pathol; 2010 May; 34(5):627-35. PubMed ID: 20414098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic thyroid carcinoma presenting as malignant pleural effusion: A cytologic review of 5 cases.
    Vyas M; Harigopal M
    Diagn Cytopathol; 2016 Dec; 44(12):1085-1089. PubMed ID: 27456348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody.
    Hu Y; Hartmann A; Stoehr C; Zhang S; Wang M; Tacha D; Montironi R; Lopez-Beltran A; Cheng L
    J Clin Pathol; 2012 Mar; 65(3):254-6. PubMed ID: 22135028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature.
    Ates Ozdemir D; Usubutun A
    Pathol Oncol Res; 2016 Jul; 22(3):593-9. PubMed ID: 26797858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
    Nonaka D; Chiriboga L; Soslow RA
    Am J Surg Pathol; 2008 Oct; 32(10):1566-71. PubMed ID: 18724243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.